Talk to More Primary Prevention Patients About the Benefits and Risks of Statins

May 2016

More patients will take statins for PRIMARY prevention of CV disease.

We know statins improve outcomes for SECONDARY prevention. But what about patients who DON'T have CV disease?

Up until now, evidence has been murkier...especially in nonwhites.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote